DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Christou GA, Kiortsis DN.
The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update.
Hormones (Athens) 2015;
14 (03) 370-375
We do not assume any responsibility for the contents of the web pages of other providers.